3-aminobenzamide has been researched along with Cirrhosis in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Fibrosis is one of the major pathological features of hypertensive vascular disease." | 5.39 | Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. ( Deng, S; Huang, D; Huang, K; Wang, L; Wang, R; Wang, Y; Zhang, C; Zhang, F; Zhang, Y, 2013) |
"Fibrosis is one of the major pathological features of hypertensive vascular disease." | 1.39 | Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. ( Deng, S; Huang, D; Huang, K; Wang, L; Wang, R; Wang, Y; Zhang, C; Zhang, F; Zhang, Y, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Y | 1 |
Wang, L | 1 |
Zhang, F | 1 |
Zhang, C | 1 |
Deng, S | 1 |
Wang, R | 1 |
Zhang, Y | 1 |
Huang, D | 1 |
Huang, K | 1 |
1 other study available for 3-aminobenzamide and Cirrhosis
Article | Year |
---|---|
Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Benzamides; Cells, Cultured; Enzyme Inhibitors; Fibrosis; | 2013 |